Introduction {#sec1-1}
============

Basal cell carcinoma (BCC) is the most common malignant skin tumor.\[[@ref1][@ref2]\] Although mortality attributable to BCC is not high, the disease is responsible for considerable morbidity and thus imposes a growing burden on health care services. Local tissue destruction and disfigurement can be large, if not limited by early detection and treatment.\[[@ref1][@ref3]\]

There is evidence that the number of patients who develop more than one BCC is increasing;\[[@ref3][@ref4]\] it is clear that all the problems of patients with single BCC are multiplied in ones with multiple BCC (mBCC).

Furthermore, the number of non-melanocytic skin cancers (NMSC) is a risk factor not only for recurrence of previous tumor,\[[@ref5]\] but also for the formation of new ones.\[[@ref6]\] So, patients with mBCC are prone to both recurrence of previous tumor and development of new BCCs.\[[@ref5]--[@ref8]\] Risk of other cancers also appears to be increased among patients with mBCC.\[[@ref9][@ref10]\]

On the other hand, chemopreventive studies have demonstrated the ability of retinoids to prevent the development of skin cancers, particularly in patients with mBCC.\[[@ref11]\]

So the identification of risk factors of mBCC is very important; thus, the high-risk patients can be recognized and followed up for recurrence and/or development of new tumor(s), trained to examine their skin regularly and visit their physician, as soon as a new skin lesion is formed, and screened serially for other malignancies.

Several factors have been suggested as risk factors of mBCC development in different previous studies, such as age,\[[@ref12][@ref13]\] male sex,\[[@ref14]\] skin phototype (I, II),\[[@ref14][@ref15]\] frequent sun exposure and sunburn,\[[@ref3][@ref16]\] severe actinic damage,\[[@ref15]\] history of radiotherapy,\[[@ref17]\] numbers of tumors already present,\[[@ref7][@ref8][@ref18]\] tumor size \>1 cm,\[[@ref12]\] truncal tumor,\[[@ref19]--[@ref21]\] family history of skin tumors,\[[@ref22]\] low DNA repair capacity,\[[@ref23]\] glutathione S-transferase and cytochrome P450 polymorphism,\[[@ref14][@ref24]\] tumor necrosis factor (TNF) microsatellite polymorphism,\[[@ref14][@ref25]\] and *PTCH* gene polymorphism.\[[@ref26]\]

The purpose of this study was to evaluate clinical risk factors in patients with mBCC.

Patients and Methods {#sec1-2}
====================

Patients with histologically proven BCC, who were referred to our skin tumor clinic (*n* = 218), were divided into two groups (single BCC and mBCC) according to the number of their tumors. Patients with xeroderma pigmentosa, nevoid BCC syndrome, Rombo syndrome, Bazex syndrome, or any other well-defined syndrome with mBCC were excluded. All these patients had been visited and examined by expert dermatologists to ensure data accuracy. Their profiles were reviewed for age at the time of tumor appearance, sex, previous and present outdoor work, history of smoking, drug abuse and alcohol consumption, past medical history and family history of cutaneous and non-cutaneous cancers, birth area, and previous and present residency area. Patients' birth area and previous and present residency area were categorized into three subgroups: "tropical and subtropical", "Caspian", and "mountainous", according to our National Geographic Institute classification. Skin phototype, eye and hair color, photo damaging lesions (including freckle, deep facial wrinkles, cutis rhomboids, telangiectasia, senile comedones, seborrheic keratosis, senile lentigo, actinic keratosis), recreational sun exposure, arsenic exposure, history of radiotherapy, date of radiotherapy, underlying skin at the site of tumor, history of trauma to tumor site, anatomic site of tumor, and tumor pathology were recorded as well.

 {#sec2-1}

### Statistical analysis {#sec3-1}

The involvement of the various factors in the development of mBCC was analyzed by logistic regression. SPSS statistical software package for Windows, version 12.0 (SPSS Inc., Chicago, IL, USA) was used to perform the statistical analysis. *P* values less than 0.05 were considered significant.

Results {#sec1-3}
=======

Of all the 218 patients who entered the study with histologically confirmed BCC, 146 patients (67%) had single BCC and 72 (33%) had mBCC. The number of tumors in mBCC group varied between 2 and 30, with a mean of 3.9 and standard deviation of 4.2.

Neither any statistical difference was detected when testing for age at the time of tumor appearance, sex, previous or present outdoor work, previous or present residency area, history of smoking, drug abuse, and alcohol consumption, history of trauma to tumor site, personal or family history of non-skin cancer, nor could we discover any significant risk of mBCC when testing for eye or hair color, skin phototype, freckle, deep facial wrinkles, cutis rhomboids, telangiectasia, senile comedones, seborrheic or actinic keratosis, recreational sun exposure, arsenic exposure, anatomic site of tumor \[[Table 1](#T1){ref-type="table"}\]. From several parameters which were investigated in this study, mountainous birth area, past medical history of BCC, history of radiotherapy (in childhood due to tinea capitis), abnormal underlying skin at tumor site, and pigmented pathologic type of tumor showed significant differences between the two groups \[[Table 2](#T2){ref-type="table"}\].
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Frequency of studied parameters in single BCC and multiple BCC (mBCC) groups
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Risk factors with significant differences between single BCC and multiple BCC groups
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Discussion {#sec1-4}
==========

We investigated the clinical risk factors associated with mBCC in comparison with single BCC.

We found that the patients who were born in mountainous area had significantly increased risk of mBCCs. To our knowledge, this had not been reported before. One possible explanation could be the genetic susceptibility secondary to ethnic affinity. The genetic factors associated with mBCC, particularly *PTCH* gene polymorphism,\[[@ref26]\] have been investigated in several studies; glutathione *S*-transferase, cytochrome P450 and TNF polymorphism have been suggested as other genetically determined risk factors for mBCC.\[[@ref14][@ref24][@ref25]\]

From personal history and family history of skin and non-skin cancers, it was found that only personal history of skin cancer was significantly associated with mBCC in our study. This result is comparable with the result of several previous studies which reported the number of BCC as the main risk factor for development of a new tumor.\[[@ref7][@ref8][@ref18]\] Our data suggest that history of radiotherapy is a strong risk factor for mBCCs. All patients with positive history of radiotherapy had received it because of tinea capitis at childhood. However, latent period between radiotherapy and tumor appearance showed no significant difference between the two groups.

We also found that abnormal underlying skin -- including radiodermatitis, scar, chronic ulcer, actinic elastosis, and nevus -- at the site of tumor was significantly more common among patients with mBCC; as this includes radiodermatitis too, this result may be secondary to history of radiotherapy and have an overlap with it.

Our data showed that pigmented pathologic type of BCC was significantly associated with mBCC. Czarencki *et al*. reported that the type of NMSC at presentation did not affect the rate of development of new lesions. However, they added that this factor may be important when patients are followed for longer.\[[@ref27]\] As pathologic type of BCC was undetermined in some of our patients, more accurate evaluation of this factor is advisable.

Male sex and old age were identified as significant risk factors in some studies. These studies have reported that men and those over the age of 60 years were at increased risk for mBCC,\[[@ref12][@ref14]\] but other studies did not confirm it.\[[@ref13]\] In our study, sex and age were not significant risk factors for mBCC.

A popular belief is that BCC is the result of cumulative life exposure to UV radiation. Some studies have suggested a different etiology, indicating that sun exposure before the age of 20 years and also intermittent sun exposure could be more important in the development of BCC.\[[@ref28][@ref29]\] Our results do not support this notion, as neither outdoor work nor recreational sun exposure (intermittent sun exposure) was found as significant factors in our study. Furthermore, none of the photodamaging lesions (freckle, deep facial wrinkles, cutis rhomboids, telangiectasia, senile comedon, seborrheic keratosis, senile lentigo, and actinic keratosis) was associated with mBCCs in our study.

Some studies have suggested that the rate of new NMSC formation appeared to be higher in populations living near the equator,\[[@ref15][@ref27]\] but residency area was not found as a significant risk factor in our study.

Smoking, drug abuse, and alcohol drinking did not show significant differences between the two groups. Similarly, Lear *et al*. reported no significant difference between mBCC and single BCC in terms of smoking history.\[[@ref3]\] However, to our knowledge, neither drug abuse nor alcohol drinking was investigated in previous studies.

Conflicting results have been reported about skin phototype. An inability to tan (skin phototypes I and II) was identified as a significant risk factor in some large studies,\[[@ref15]\] but other studies did not find it as a significant risk factor for mBCC. A significant relationship was not found between skin phototype and risk of new BCC formation in our study, as well.

Hair and eye color were not significant risk factors in our study. Arsenic exposure was also not found as a risk factor for mBCC.

Several studies have reported that the patients whose first BCC was truncal were significantly at higher risk of mBCC.\[[@ref19]--[@ref21]\] We could not evaluate this factor, as we had only four patients with truncal tumors, which were not enough for statistical analysis. This was a limitation of our study. Furthermore, as our investigation was a retrospective study based on recorded data in patients' profile, we could not evaluate the role of some possible risk factors such as tumor size and patients' genotypes for glutathione *S*-transferase, cytochrome P450, TNF and *PTCH* gene polymorphism in our study. Further prospective studies are required to evaluate these factors.

In conclusion, we tried to elucidate some risk factors among patients with mBCC. We found mountainous birth area, past medical history of BCC, history of radiotherapy at childhood, abnormal underlying skin and pigmented pathologic type of tumor as significant risk factors of mBCC. Anyway, the high rate of additional occurrences of skin cancers among patients with previously diagnosed BCC emphasizes the need for continued follow-up of these individuals. Those with higher risk require closest screening.
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